• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins.色甘酸钠的作用方式,使用两种抗原性不同的大鼠反应素进行“双重致敏”对速发型过敏反应的研究。
Clin Exp Immunol. 1970 Nov;7(5):745-57.
2
Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.色甘酸钠(FPL 670)(“因他舒”):一种反应素抗体-抗原机制的特异性抑制剂。
Nature. 1967 Dec 30;216(5122):1328-9. doi: 10.1038/2161328a0.
3
Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.Ro 22 - 3747:一种用于治疗速发型超敏反应性疾病的新型抗过敏药物。
J Pharmacol Exp Ther. 1984 Jan;228(1):57-64.
4
Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.β-肾上腺素能兴奋剂和色甘酸钠对过敏反应机制的体内和体外抑制作用比较
Immunology. 1971 Nov;21(5):729-39.
5
Allergy as inflammatory reactions.过敏作为炎症反应。
Ann Allergy. 1971 Aug;29(8):410-7.
6
Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung.色甘酸钠。在肺速发型超敏反应的三种体外模型中的活性。
Int Arch Allergy Appl Immunol. 1970;38(2):217-24.
7
A comparative study of the anti-allergic effects of disodium baicalein 6-phosphate (BPS) and disodium cromoglycate (DSCG).
Jpn J Pharmacol. 1977 Feb;27(1):31-8. doi: 10.1254/jjp.27.31.
8
Immunochemical mechanisms of immediate-type hypersensitivity reactions.速发型超敏反应的免疫化学机制。
Clin Exp Immunol. 1970 Jan;6(1):1-12.
9
[Mechanism of action of reagin antibodies (IgE) in helminthic allergy].[反应素抗体(IgE)在蠕虫过敏中的作用机制]
Veterinariia. 1975 Nov(11):51-5.
10
Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7S-gamma-2 antibody.用色甘酸钠对大鼠被动皮肤过敏反应的研究。I. 抗二硝基苯7S-γ-2抗体引起的皮肤反应
Immunology. 1970 Sep;19(3):469-79.

引用本文的文献

1
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.色甘酸盐药物通过促进膜联蛋白A1的释放来抑制U937细胞中类花生酸的生成。
Biochem Pharmacol. 2009 Jun 15;77(12):1814-26. doi: 10.1016/j.bcp.2009.03.010. Epub 2009 Mar 24.
2
The effect of inhaled and intranasal sodium cromoglycate on symptoms of upper respiratory tract infections.吸入性和鼻内用色甘酸钠对上呼吸道感染症状的影响。
Clin Exp Allergy. 1996 Sep;26(9):1045-50. doi: 10.1111/j.1365-2222.1996.tb00642.x.
3
Dose-response study of sodium cromoglycate in exercise-induced asthma.色甘酸钠对运动诱发性哮喘的剂量反应研究。
Thorax. 1982 Sep;37(9):663-6. doi: 10.1136/thx.37.9.663.
4
Calcium antagonists in exercise-induced asthma.运动诱发性哮喘中的钙拮抗剂
Br Med J (Clin Res Ed). 1981 Mar 21;282(6268):932-3. doi: 10.1136/bmj.282.6268.932.
5
Treatment of pyoderma gangrenosum with disodium cromoglycate.用色甘酸钠治疗坏疽性脓皮病。
Dig Dis Sci. 1984 Feb;29(2):183-5. doi: 10.1007/BF01317063.
6
Protective effect of drugs on bronchoconstriction induced by sulphur dioxide.药物对二氧化硫诱导的支气管收缩的保护作用。
Thorax. 1982 Sep;37(9):671-5. doi: 10.1136/thx.37.9.671.
7
Effect of lignocaine, sodium cromoglycate, and ipratropium bromide in exercise-induced asthma.利多卡因、色甘酸钠和异丙托溴铵对运动诱发性哮喘的作用。
Thorax. 1982 Oct;37(10):737-40. doi: 10.1136/thx.37.10.737.
8
A protective action of disodium cromoglycate against the contraction of guinea-pig ileum induced by various pharmacological stimulants.色甘酸钠对多种药理刺激物诱导的豚鼠回肠收缩的保护作用。
Agents Actions. 1980 Apr;10(1 Pt 2):8-14. doi: 10.1007/BF02024172.
9
Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. II. A comparison of the rat anti-dnp 7S 2 and rat reagin induced cutaneous reactions.用色甘酸钠对大鼠被动皮肤过敏反应的研究。II. 大鼠抗二硝基苯7S 2和大鼠反应素诱导的皮肤反应比较。
Immunology. 1971 Sep;21(3):405-17.
10
Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.色甘酸钠:其作用机制、药理学、治疗效果及应用综述
Drugs. 1974;7(3):164-282. doi: 10.2165/00003495-197407030-00002.

本文引用的文献

1
Proteolytic enzymes.蛋白水解酶
Annu Rev Biochem. 1960;29:45-72. doi: 10.1146/annurev.bi.29.070160.000401.
2
THE MECHANISM OF ANAPHYLAXIS. I. PRODUCTION AND BIOLOGICAL PROPERTIES OF 'MAST CELL SENSITIZING' ANTIBODY.过敏反应的机制。I. “肥大细胞致敏”抗体的产生及生物学特性。
Immunology. 1964 Nov;7(6):681-99.
3
A COMPARISON OF THE SPECIFICITY OF INHIBITION BY PHOSPHONATE ESTERS OF THE FIRST COMPONENT OF COMPLEMENT AND THE ANTIGEN-INDUCED RELEASE OF HISTAMINE FROM GUINEA PIG LUNG.膦酸酯对补体第一成分抑制特异性与抗原诱导豚鼠肺组织组胺释放的比较
J Exp Med. 1964 Oct 1;120(4):491-506. doi: 10.1084/jem.120.4.491.
4
Anaphylaxis in chopped guinea pig lung. I. Effect of peptidase substrates and inhibitors.豚鼠肺切碎物中的过敏反应。I. 肽酶底物和抑制剂的作用。
J Exp Med. 1961 Mar 1;113(3):521-39. doi: 10.1084/jem.113.3.521.
5
Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.色甘酸钠(FPL 670)(“因他舒”):一种反应素抗体-抗原机制的特异性抑制剂。
Nature. 1967 Dec 30;216(5122):1328-9. doi: 10.1038/2161328a0.
6
Antigen induced release of histamine and SRS-A from human lung passively sensitized with reaginic serum.抗原诱导组胺和慢反应物质A从用反应素血清被动致敏的人肺中释放。
Nature. 1967 Oct 21;216(5112):283-4. doi: 10.1038/216283a0.
7
Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7S-gamma-2 antibody.用色甘酸钠对大鼠被动皮肤过敏反应的研究。I. 抗二硝基苯7S-γ-2抗体引起的皮肤反应
Immunology. 1970 Sep;19(3):469-79.
8
Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions.色甘酸钠对某些被动皮肤过敏反应的影响。
J Immunol. 1969 Dec;103(6):1428-30.
9
Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate.用两种同源的类反应素抗体诱导大鼠被动皮肤过敏反应及其用色甘酸二钠的特异性抑制作用。
Immunology. 1969 Jun;16(6):749-60.
10
Inhibition of allergic reactions in man and other species by cromoglycate.色甘酸盐对人和其他物种过敏反应的抑制作用。
Int Arch Allergy Appl Immunol. 1970;38(1):68-77. doi: 10.1159/000230260.

色甘酸钠的作用方式,使用两种抗原性不同的大鼠反应素进行“双重致敏”对速发型过敏反应的研究。

Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins.

作者信息

Cox J S, Orr T S, Pollard M C, Gwilliam J

出版信息

Clin Exp Immunol. 1970 Nov;7(5):745-57.

PMID:4101095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1712884/
Abstract

The mode of action of disodium cromoglycate has been investigated to determine at what stage in immediate type hypersensitivity reactions the compound is effective. studies using rat subcutaneous connective tissue sensitized with rat reagin revealed that the compound inhibited the allergic release of histamine if present during antigen challenge. The presence of the compound during sensitization had no effect on antigen-induced release of histamine provided the compound was removed prior to antigen challenge. Tissues which had undergone a primary antigen challenge in the presence of disodium cromoglycate did not release histamine when the compound was removed and the tissues rechallenged. These findings indicated that antigen/antibody interaction occurred in the presence of the compound resulting in desensitization to a subsequent antigen challenge. To corroborate the evidence of the studies passive cutaneous anaphylactic reactions (PCA) were undertaken using tissue sites sensitized with two reaginic antibodies which permitted a sequence of antigen challenges. Results from these reactions demonstrated that it was possible to desensitize tissue, without the release of the mediators of anaphylaxis, by an antigen challenge and disodium cromoglycate treatment. In these sites sensitized with two antibodies the immunological reactivity was maintained following a primary antigen challenge and disodium cromoglycate treatment, as a subsequent challenge with the dissimilar antigen produced a good PCA reaction. It would appear that disodium cromoglycate acts either directly or indirectly at a stage following antigen/antibody reaction but prior to the release of the mediators of anaphylaxis.

摘要

已对色甘酸二钠的作用方式进行了研究,以确定该化合物在速发型超敏反应的哪个阶段有效。使用用大鼠反应素致敏的大鼠皮下结缔组织进行的研究表明,如果在抗原攻击期间存在该化合物,它会抑制组胺的过敏释放。如果在致敏期间存在该化合物,只要在抗原攻击之前将其去除,就不会对抗原诱导的组胺释放产生影响。在色甘酸二钠存在下经历过初次抗原攻击的组织,当去除该化合物并再次攻击这些组织时,不会释放组胺。这些发现表明,在该化合物存在的情况下发生了抗原/抗体相互作用,从而导致对随后的抗原攻击产生脱敏作用。为了证实这些研究的证据,使用用两种反应素抗体致敏的组织部位进行了被动皮肤过敏反应(PCA),这允许进行一系列抗原攻击。这些反应的结果表明,通过抗原攻击和色甘酸二钠处理,可以使组织脱敏,而不会释放过敏反应介质。在这些用两种抗体致敏的部位,初次抗原攻击和色甘酸二钠处理后免疫反应性得以维持,因为随后用不同抗原进行攻击会产生良好的PCA反应。色甘酸二钠似乎在抗原/抗体反应之后但在过敏反应介质释放之前的某个阶段直接或间接起作用。